Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. IV. Partially deglycosylated derivatives.
- 1 January 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 40 (7) , 941-945
- https://doi.org/10.7164/antibiotics.40.941
Abstract
Chloropolysporins A, B and C, new members of the glycopeptide antibiotic family, were enzymatically and chemically converted to their partially deglycosylated derivatives. The .alpha.- and .beta.-avoparcins were also deglycosylated by the same method. The conversions were achieved by treatments with rhamnosidase (Naringinase) and .alpha.-mannosidase, and by mild acid hydrolysis.This publication has 6 references indexed in Scilit:
- Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. I. Taxonomy of producing organism.The Journal of Antibiotics, 1987
- Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. III. Structure elucidation of chloropolysporins.The Journal of Antibiotics, 1987
- Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. II. Fermentation, isolation and physico-chemical characterization.The Journal of Antibiotics, 1987
- Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products.The Journal of Antibiotics, 1984
- Components and degradation compounds of the avoparcin complex.The Journal of Antibiotics, 1983
- Structure Studies on VancomycinJournal of Medicinal Chemistry, 1965